** Shares of Cann Group Ltd CAN.AX gain as much as 5.5% to
A$0.290, their biggest intra-day rise since Nov 9
** The medicinal cannabis manufacturer says it has received
a GMP license from Therapeutic Goods Administration to produce
therapeutic goods for its Southern facility urn:newsml:reuters.com:*:nASN0022D1
** Co says dried cannabis flower products manufactured under
the license are expected to be available to patients within the
next few weeks
** Nearly 1.3 mln shares change hands, 4.2 times more
compared with the 30-day average volume of 302,320 shares
** Stock had nearly halved in 2021
(Reporting by Archishma Iyer)
((Archishma.Iyer@thomsonreuters.com;))